Century buys a startup, raises funding in cell therapy expansion
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Superstring Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US-based immune therapy developer Zenas has significant operations in China.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
With this, Sironax has raised over $300 million to date.
/PRNewswire/ -- Sironax, an emerging biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related...